The human adaptive immune system has evolved to provide a sophisticated response to a vast body of pathogenic microbes and toxic substances. The primary mediators of this response are T and B lymphocytes. Antigenic peptides presented at the surface of infected cells by major histocompatibility complex (MHC) molecules are recognised by T cell receptors (TCRs) with exceptional specificity. This specificity arises from the enormous diversity in TCR sequence and structure generated through an imprecise process of somatic gene recombination that takes place during T cell development. Quantification of the TCR repertoire through the analysis of data produced by high-throughput RNA sequencing allows for a characterisation of the immune response to disease over time and between patients, and the development of methods for diagnosis and therapeutic design. The latest version of the software package Decombinator extracts and quantifies the TCR repertoire with improved accuracy and compatibility with complementary experimental protocols and external computational tools. The software has been extended for analysis of fragmented short-read
data from single cells, comparing favourably with two alternative tools. The development of cell-based therapeutics and vaccines is incomplete without an understanding of molecular level interactions. The breadth of TCR diversity and cross-reactivity presents a barrier for comprehensive structural resolution of the repertoire by traditional means. Computational modelling of TCR structures and TCR-pMHC complexes provides an efficient alternative. Four generalpurpose protein-protein docking platforms were compared in their ability to accurately model TCR-pMHC complexes. Each platform was evaluated against an expanded benchmark of docking test cases and in the context of varying additional information about the binding interface.
Continual innovation in structural modelling techniques sets the stage for novel automated tools for TCR design. A prototype platform has been developed, integrating structural modelling and an optimisation routine, to engineer desirable features into TCR and TCR-pMHC complex models
